Bản hướng dẫn thực thi (IG) dành cho các hệ thống thông tin Y tế tại Việt Nam
1.0.0 - CI Build
Bản hướng dẫn thực thi (IG) dành cho các hệ thống thông tin Y tế tại Việt Nam
1.0.0 - CI Build
Bản hướng dẫn thực thi (IG) dành cho các hệ thống thông tin Y tế tại Việt Nam, published by Cục Công nghệ thông tin - Bộ Y tế. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7vn/vn-core-ig/ and changes regularly. See the Directory of published versions
Summary
| Defining URL: | http://fhir.ehealth.gov.vn/core/ValueSet/vaccine-code |
| Version: | 1.0.0 |
| Name: | ValueSet-Vaccine_Administered_Code |
| Title: | ValueSet dành cho Vaccine Code |
| Status: | Active as of 2020-12-30 |
| Definition: | This identifies the vaccine substance administered - CVX codes. |
| Publisher: | , Link, Link |
| Source Resource: | XML / JSON / Turtle |
References
This value set includes codes based on the following rules:
http://hl7.org/fhir/sid/cvx version Not Stated (use latest from terminology server)| Code | Display |
| 01 | diphtheria, tetanus toxoids and pertussis vaccine |
| 02 | trivalent poliovirus vaccine, live, oral |
| 03 | measles, mumps and rubella virus vaccine |
| 04 | measles and rubella virus vaccine |
| 05 | measles virus vaccine |
| 06 | rubella virus vaccine |
| 07 | mumps virus vaccine |
| 08 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
| 09 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
| 10 | poliovirus vaccine, inactivated |
| 100 | pneumococcal conjugate vaccine, 7 valent |
| 101 | typhoid Vi capsular polysaccharide vaccine |
| 102 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
| 103 | meningococcal C conjugate vaccine |
| 104 | hepatitis A and hepatitis B vaccine |
| 105 | vaccinia (smallpox) vaccine, diluted |
| 106 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
| 107 | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |
| 108 | meningococcal ACWY vaccine, unspecified formulation |
| 109 | pneumococcal vaccine, unspecified formulation |
| 11 | pertussis vaccine |
| 110 | DTaP-hepatitis B and poliovirus vaccine |
| 111 | influenza virus vaccine, live, attenuated, for intranasal use |
| 112 | tetanus toxoid, unspecified formulation |
| 113 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
| 114 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |
| 115 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
| 116 | rotavirus, live, pentavalent vaccine |
| 117 | varicella zoster immune globulin (Investigational New Drug) |
| 118 | human papilloma virus vaccine, bivalent |
| 119 | rotavirus, live, monovalent vaccine |
| 12 | diphtheria antitoxin |
| 120 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
| 121 | zoster vaccine, live |
| 122 | rotavirus vaccine, unspecified formulation |
| 123 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |
| 125 | Novel Influenza-H1N1-09, live virus for nasal administration |
| 126 | Novel influenza-H1N1-09, preservative-free, injectable |
| 127 | Novel influenza-H1N1-09, injectable |
| 128 | Novel influenza-H1N1-09, all formulations |
| 129 | Japanese Encephalitis vaccine, unspecified formulation |
| 13 | tetanus immune globulin |
| 130 | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |
| 131 | Historical record of a typhus vaccination |
| 132 | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |
| 133 | pneumococcal conjugate vaccine, 13 valent |
| 134 | Japanese Encephalitis vaccine for intramuscular administration |
| 135 | influenza, high dose seasonal, preservative-free |
| 136 | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |
| 137 | HPV, unspecified formulation |
| 138 | tetanus and diphtheria toxoids, not adsorbed, for adult use |
| 139 | Td(adult) unspecified formulation |
| 14 | immune globulin, unspecified formulation |
| 140 | Influenza, seasonal, injectable, preservative free |
| 141 | Influenza, seasonal, injectable |
| 142 | tetanus toxoid, not adsorbed |
| 143 | Adenovirus, type 4 and type 7, live, oral |
| 144 | seasonal influenza, intradermal, preservative free |
| 147 | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |
| 148 | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
| 149 | influenza, live, intranasal, quadrivalent |
| 15 | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |
| 150 | Influenza, injectable, quadrivalent, preservative free |
| 151 | influenza nasal, unspecified formulation |
| 152 | Pneumococcal Conjugate, unspecified formulation |
| 153 | Influenza, injectable, Madin Darby Canine Kidney, preservative free |
| 155 | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |
| 156 | Rho(D) Immune globulin- IV or IM |
| 157 | Rho(D) Immune globulin - IM |
| 158 | influenza, injectable, quadrivalent, contains preservative |
| 159 | Rho(D) Unspecified formulation |
| 16 | influenza virus vaccine, whole virus |
| 160 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |
| 161 | Influenza, injectable,quadrivalent, preservative free, pediatric |
| 162 | meningococcal B vaccine, fully recombinant |
| 163 | meningococcal B vaccine, recombinant, OMV, adjuvanted |
| 164 | meningococcal B, unspecified formulation |
| 165 | Human Papillomavirus 9-valent vaccine |
| 166 | influenza, intradermal, quadrivalent, preservative free, injectable |
| 167 | meningococcal vaccine of unknown formulation and unknown serogroups |
| 168 | Seasonal trivalent influenza vaccine, adjuvanted, preservative free |
| 169 | Hep A, live attenuated-IM |
| 17 | Haemophilus influenzae type b vaccine, conjugate unspecified formulation |
| 170 | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
| 171 | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |
| 172 | cholera, WC-rBS |
| 173 | cholera, BivWC |
| 174 | cholera, live attenuated |
| 175 | Human Rabies vaccine from human diploid cell culture |
| 176 | Human rabies vaccine from Chicken fibroblast culture |
| 177 | pneumococcal conjugate vaccine, 10 valent |
| 178 | Non-US bivalent oral polio vaccine (types 1 and 3) |
| 179 | Non-US monovalent oral polio vaccine, unspecified formulation |
| 18 | rabies vaccine, for intramuscular injection RETIRED CODE |
| 180 | tetanus immune globulin |
| 181 | anthrax immune globulin |
| 182 | Oral Polio Vaccine, Unspecified formulation |
| 183 | Yellow fever vaccine alternative formulation |
| 184 | Yellow fever vaccine, unspecified formulation |
| 185 | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |
| 186 | Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative |
| 187 | zoster vaccine recombinant |
| 188 | zoster vaccine, unspecified formulation |
| 189 | Hepatitis B vaccine (recombinant), CpG adjuvanted |
| 19 | Bacillus Calmette-Guerin vaccine |
| 20 | diphtheria, tetanus toxoids and acellular pertussis vaccine |
| 21 | varicella virus vaccine |
| 22 | DTP-Haemophilus influenzae type b conjugate vaccine |
| 23 | plague vaccine |
| 24 | anthrax vaccine |
| 25 | typhoid vaccine, live, oral |
| 26 | cholera vaccine, unspecified formulation |
| 27 | botulinum antitoxin |
| 28 | diphtheria and tetanus toxoids, adsorbed for pediatric use |
| 29 | cytomegalovirus immune globulin, intravenous |
| 30 | hepatitis B immune globulin |
| 31 | hepatitis A vaccine, pediatric dosage, unspecified formulation |
| 32 | meningococcal polysaccharide vaccine (MPSV4) |
| 33 | pneumococcal polysaccharide vaccine, 23 valent |
| 34 | rabies immune globulin |
| 35 | tetanus toxoid, adsorbed |
| 36 | varicella zoster immune globulin |
| 37 | yellow fever vaccine |
| 38 | rubella and mumps virus vaccine |
| 39 | Japanese Encephalitis Vaccine SC |
| 40 | rabies vaccine, for intradermal injection |
| 41 | typhoid vaccine, parenteral, other than acetone-killed, dried |
| 42 | hepatitis B vaccine, adolescent/high risk infant dosage |
| 43 | hepatitis B vaccine, adult dosage |
| 44 | hepatitis B vaccine, dialysis patient dosage |
| 45 | hepatitis B vaccine, unspecified formulation |
| 46 | Haemophilus influenzae type b vaccine, PRP-D conjugate |
| 47 | Haemophilus influenzae type b vaccine, HbOC conjugate |
| 48 | Haemophilus influenzae type b vaccine, PRP-T conjugate |
| 49 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
| 50 | DTaP-Haemophilus influenzae type b conjugate vaccine |
| 51 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
| 52 | hepatitis A vaccine, adult dosage |
| 53 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
| 54 | adenovirus vaccine, type 4, live, oral |
| 55 | adenovirus vaccine, type 7, live, oral |
| 62 | human papilloma virus vaccine, quadrivalent |
| 66 | Lyme disease vaccine |
| 69 | parainfluenza-3 virus vaccine |
| 71 | respiratory syncytial virus immune globulin, intravenous |
| 74 | rotavirus, live, tetravalent vaccine |
| 75 | vaccinia (smallpox) vaccine |
| 76 | Staphylococcus bacteriophage lysate |
| 77 | tick-borne encephalitis vaccine |
| 78 | tularemia vaccine |
| 79 | vaccinia immune globulin |
| 80 | Venezuelan equine encephalitis, live, attenuated |
| 801 | AS03 Adjuvant |
| 81 | Venezuelan equine encephalitis, inactivated |
| 82 | adenovirus vaccine, unspecified formulation |
| 83 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
| 84 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
| 85 | hepatitis A vaccine, unspecified formulation |
| 86 | immune globulin, intramuscular |
| 87 | immune globulin, intravenous |
| 88 | influenza virus vaccine, unspecified formulation |
| 89 | poliovirus vaccine, unspecified formulation |
| 90 | rabies vaccine, unspecified formulation |
| 91 | typhoid vaccine, unspecified formulation |
| 92 | Venezuelan equine encephalitis vaccine, unspecified formulation |
| 93 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
| 94 | measles, mumps, rubella, and varicella virus vaccine |
| 95 | tuberculin skin test; old tuberculin, multipuncture device |
| 96 | tuberculin skin test; purified protein derivative solution, intradermal |
| 97 | tuberculin skin test; purified protein derivative, multipuncture device |
| 98 | tuberculin skin test; unspecified formulation |
| 998 | no vaccine administered |
http://snomed.info/sct version Not Stated (use latest from terminology server) where concept is-a 787859002 (Vaccine product)http://www.whocc.no/atc version Not Stated (use latest from terminology server)
Expansion from tx.fhir.org based on:
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
| System | Code | Display (en) | JSON | XML |
http://hl7.org/fhir/sid/cvx | 01 | DTP | ||
http://hl7.org/fhir/sid/cvx | 02 | OPV, trivalent | ||
http://hl7.org/fhir/sid/cvx | 03 | MMR | ||
http://hl7.org/fhir/sid/cvx | 04 | M/R | ||
http://hl7.org/fhir/sid/cvx | 05 | measles | ||
http://hl7.org/fhir/sid/cvx | 06 | rubella | ||
http://hl7.org/fhir/sid/cvx | 07 | mumps | ||
http://hl7.org/fhir/sid/cvx | 08 | Hep B, adolescent or pediatric | ||
http://hl7.org/fhir/sid/cvx | 09 | Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed | ||
http://hl7.org/fhir/sid/cvx | 10 | IPV | ||
http://hl7.org/fhir/sid/cvx | 100 | pneumococcal conjugate PCV 7 | ||
http://hl7.org/fhir/sid/cvx | 101 | typhoid, ViCPs | ||
http://hl7.org/fhir/sid/cvx | 102 | DTP-Hib-Hep B | ||
http://hl7.org/fhir/sid/cvx | 103 | meningococcal C conjugate | ||
http://hl7.org/fhir/sid/cvx | 104 | Hep A-Hep B | ||
http://hl7.org/fhir/sid/cvx | 105 | vaccinia (smallpox) diluted | ||
http://hl7.org/fhir/sid/cvx | 106 | DTaP, 5 pertussis antigens | ||
http://hl7.org/fhir/sid/cvx | 107 | DTaP, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 108 | meningococcal ACWY, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 109 | pneumococcal, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 11 | pertussis | ||
http://hl7.org/fhir/sid/cvx | 110 | DTaP-Hep B-IPV | ||
http://hl7.org/fhir/sid/cvx | 111 | Influenza, live, trivalent, intranasal, PF | ||
http://hl7.org/fhir/sid/cvx | 112 | tetanus toxoid, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 113 | Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed | ||
http://hl7.org/fhir/sid/cvx | 114 | meningococcal MCV4P | ||
http://hl7.org/fhir/sid/cvx | 115 | Tdap | ||
http://hl7.org/fhir/sid/cvx | 116 | rotavirus, pentavalent | ||
http://hl7.org/fhir/sid/cvx | 117 | VZIG (IND) | ||
http://hl7.org/fhir/sid/cvx | 118 | HPV, bivalent | ||
http://hl7.org/fhir/sid/cvx | 119 | rotavirus, monovalent | ||
http://hl7.org/fhir/sid/cvx | 12 | diphtheria antitoxin | ||
http://hl7.org/fhir/sid/cvx | 120 | DTaP-Hib-IPV | ||
http://hl7.org/fhir/sid/cvx | 121 | zoster live | ||
http://hl7.org/fhir/sid/cvx | 122 | rotavirus, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 123 | influenza, H5N1-1203 | ||
http://hl7.org/fhir/sid/cvx | 125 | Novel Influenza-H1N1-09, nasal | ||
http://hl7.org/fhir/sid/cvx | 126 | Novel influenza-H1N1-09, preservative-free | ||
http://hl7.org/fhir/sid/cvx | 127 | Novel influenza-H1N1-09 | ||
http://hl7.org/fhir/sid/cvx | 128 | Novel Influenza-H1N1-09, all formulations | ||
http://hl7.org/fhir/sid/cvx | 129 | Japanese Encephalitis, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 13 | TIG | ||
http://hl7.org/fhir/sid/cvx | 130 | DTaP-IPV | ||
http://hl7.org/fhir/sid/cvx | 131 | typhus, historical | ||
http://hl7.org/fhir/sid/cvx | 132 | DTaP-IPV-HIB-HEP B, historical | ||
http://hl7.org/fhir/sid/cvx | 133 | Pneumococcal conjugate PCV 13 | ||
http://hl7.org/fhir/sid/cvx | 134 | Japanese Encephalitis IM | ||
http://hl7.org/fhir/sid/cvx | 135 | Influenza, high-dose, trivalent, PF | ||
http://hl7.org/fhir/sid/cvx | 136 | Meningococcal MCV4O | ||
http://hl7.org/fhir/sid/cvx | 137 | HPV, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 138 | Td (adult) | ||
http://hl7.org/fhir/sid/cvx | 139 | Td(adult) unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 14 | IG, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 140 | Influenza, split virus, trivalent, PF | ||
http://hl7.org/fhir/sid/cvx | 141 | Influenza, split virus, trivalent, preservative | ||
http://hl7.org/fhir/sid/cvx | 142 | tetanus toxoid, not adsorbed | ||
http://hl7.org/fhir/sid/cvx | 143 | Adenovirus types 4 and 7 | ||
http://hl7.org/fhir/sid/cvx | 144 | influenza, seasonal, intradermal, preservative free | ||
http://hl7.org/fhir/sid/cvx | 147 | meningococcal MCV4, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 148 | Meningococcal C/Y-HIB PRP | ||
http://hl7.org/fhir/sid/cvx | 149 | Influenza, live, quadrivalent, intranasal | ||
http://hl7.org/fhir/sid/cvx | 15 | influenza, split (incl. purified surface antigen) | ||
http://hl7.org/fhir/sid/cvx | 150 | Influenza, split virus, quadrivalent, PF | ||
http://hl7.org/fhir/sid/cvx | 151 | influenza nasal, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 152 | Pneumococcal Conjugate, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 153 | Influenza, MDCK, trivalent, PF | ||
http://hl7.org/fhir/sid/cvx | 155 | Influenza, recombinant, trivalent, PF | ||
http://hl7.org/fhir/sid/cvx | 156 | Rho(D)-IG | ||
http://hl7.org/fhir/sid/cvx | 157 | Rho(D) -IG IM | ||
http://hl7.org/fhir/sid/cvx | 158 | Influenza, split virus, quadrivalent, preservative | ||
http://hl7.org/fhir/sid/cvx | 159 | Rho(D) - Unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 16 | influenza, whole | ||
http://hl7.org/fhir/sid/cvx | 160 | Influenza A monovalent (H5N1), ADJUVANTED-2013 | ||
http://hl7.org/fhir/sid/cvx | 161 | Influenza, injectable,quadrivalent, preservative free, pediatric | ||
http://hl7.org/fhir/sid/cvx | 162 | meningococcal B, recombinant | ||
http://hl7.org/fhir/sid/cvx | 163 | meningococcal B, OMV | ||
http://hl7.org/fhir/sid/cvx | 164 | meningococcal B, unspecified | ||
http://hl7.org/fhir/sid/cvx | 165 | HPV9 | ||
http://hl7.org/fhir/sid/cvx | 166 | influenza, intradermal, quadrivalent, preservative free | ||
http://hl7.org/fhir/sid/cvx | 167 | meningococcal, unknown serogroups | ||
http://hl7.org/fhir/sid/cvx | 168 | Influenza, adjuvanted, trivalent, PF | ||
http://hl7.org/fhir/sid/cvx | 169 | Hep A, live attenuated | ||
http://hl7.org/fhir/sid/cvx | 17 | Hib, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 170 | DTAP/IPV/HIB - non-US | ||
http://hl7.org/fhir/sid/cvx | 171 | Influenza, MDCK, quadrivalent, PF | ||
http://hl7.org/fhir/sid/cvx | 172 | cholera, WC-rBS | ||
http://hl7.org/fhir/sid/cvx | 173 | cholera, BivWC | ||
http://hl7.org/fhir/sid/cvx | 174 | cholera, live attenuated | ||
http://hl7.org/fhir/sid/cvx | 175 | Rabies - IM Diploid cell culture | ||
http://hl7.org/fhir/sid/cvx | 176 | Rabies - IM fibroblast culture | ||
http://hl7.org/fhir/sid/cvx | 177 | PCV10 | ||
http://hl7.org/fhir/sid/cvx | 178 | OPV bivalent | ||
http://hl7.org/fhir/sid/cvx | 179 | OPV ,monovalent, unspecified | ||
http://hl7.org/fhir/sid/cvx | 18 | rabies, intramuscular injection | ||
http://hl7.org/fhir/sid/cvx | 180 | tetanus immune globulin | ||
http://hl7.org/fhir/sid/cvx | 181 | anthrax immune globulin | ||
http://hl7.org/fhir/sid/cvx | 182 | OPV, Unspecified | ||
http://hl7.org/fhir/sid/cvx | 183 | Yellow fever vaccine live - alt | ||
http://hl7.org/fhir/sid/cvx | 184 | Yellow fever, unspecified | ||
http://hl7.org/fhir/sid/cvx | 185 | Influenza, recombinant, quadrivalent, PF | ||
http://hl7.org/fhir/sid/cvx | 186 | Influenza, MDCK, quadrivalent, preservative | ||
http://hl7.org/fhir/sid/cvx | 187 | zoster recombinant | ||
http://hl7.org/fhir/sid/cvx | 188 | zoster, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 189 | HepB-CpG | ||
http://hl7.org/fhir/sid/cvx | 19 | BCG | ||
http://hl7.org/fhir/sid/cvx | 20 | DTaP | ||
http://hl7.org/fhir/sid/cvx | 21 | varicella | ||
http://hl7.org/fhir/sid/cvx | 22 | DTP-Hib | ||
http://hl7.org/fhir/sid/cvx | 23 | plague | ||
http://hl7.org/fhir/sid/cvx | 24 | Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis | ||
http://hl7.org/fhir/sid/cvx | 25 | typhoid, oral | ||
http://hl7.org/fhir/sid/cvx | 26 | cholera, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 27 | botulinum antitoxin | ||
http://hl7.org/fhir/sid/cvx | 28 | DT (pediatric) | ||
http://hl7.org/fhir/sid/cvx | 29 | CMVIG | ||
http://hl7.org/fhir/sid/cvx | 30 | HBIG | ||
http://hl7.org/fhir/sid/cvx | 31 | Hep A, pediatric, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 32 | meningococcal MPSV4 | ||
http://hl7.org/fhir/sid/cvx | 33 | pneumococcal polysaccharide PPV23 | ||
http://hl7.org/fhir/sid/cvx | 34 | RIG | ||
http://hl7.org/fhir/sid/cvx | 35 | tetanus toxoid, adsorbed | ||
http://hl7.org/fhir/sid/cvx | 36 | VZIG | ||
http://hl7.org/fhir/sid/cvx | 37 | yellow fever live | ||
http://hl7.org/fhir/sid/cvx | 38 | rubella/mumps | ||
http://hl7.org/fhir/sid/cvx | 39 | Japanese encephalitis SC | ||
http://hl7.org/fhir/sid/cvx | 40 | rabies, intradermal injection | ||
http://hl7.org/fhir/sid/cvx | 41 | typhoid, parenteral | ||
http://hl7.org/fhir/sid/cvx | 42 | Hep B, adolescent/high risk infant | ||
http://hl7.org/fhir/sid/cvx | 43 | Hep B, adult | ||
http://hl7.org/fhir/sid/cvx | 44 | Hep B, high-dosage, dialysis or IC | ||
http://hl7.org/fhir/sid/cvx | 45 | Hep B, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 46 | Hib (PRP-D) | ||
http://hl7.org/fhir/sid/cvx | 47 | Hib (HbOC) | ||
http://hl7.org/fhir/sid/cvx | 48 | Hib (PRP-T) | ||
http://hl7.org/fhir/sid/cvx | 49 | Hib (PRP-OMP) | ||
http://hl7.org/fhir/sid/cvx | 50 | DTaP-Hib | ||
http://hl7.org/fhir/sid/cvx | 51 | Hib-Hep B | ||
http://hl7.org/fhir/sid/cvx | 52 | Hep A, adult | ||
http://hl7.org/fhir/sid/cvx | 53 | typhoid, parenteral, AKD (U.S. military) | ||
http://hl7.org/fhir/sid/cvx | 54 | adenovirus, type 4 | ||
http://hl7.org/fhir/sid/cvx | 55 | adenovirus, type 7 | ||
http://hl7.org/fhir/sid/cvx | 62 | HPV, quadrivalent | ||
http://hl7.org/fhir/sid/cvx | 66 | Lyme disease | ||
http://hl7.org/fhir/sid/cvx | 69 | parainfluenza-3 | ||
http://hl7.org/fhir/sid/cvx | 71 | RSV-IGIV | ||
http://hl7.org/fhir/sid/cvx | 74 | rotavirus, tetravalent | ||
http://hl7.org/fhir/sid/cvx | 75 | Vaccinia (smallpox, mpox), live | ||
http://hl7.org/fhir/sid/cvx | 76 | Staphylococcus bacterio lysate | ||
http://hl7.org/fhir/sid/cvx | 77 | Tick-borne encephalitis vaccine (non-US) | ||
http://hl7.org/fhir/sid/cvx | 78 | tularemia vaccine | ||
http://hl7.org/fhir/sid/cvx | 79 | vaccinia immune globulin | ||
http://hl7.org/fhir/sid/cvx | 80 | VEE, live | ||
http://hl7.org/fhir/sid/cvx | 801 | AS03 Adjuvant | ||
http://hl7.org/fhir/sid/cvx | 81 | VEE, inactivated | ||
http://hl7.org/fhir/sid/cvx | 82 | adenovirus, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 83 | Hep A, ped/adol, 2 dose | ||
http://hl7.org/fhir/sid/cvx | 84 | Hep A, ped/adol, 3 dose | ||
http://hl7.org/fhir/sid/cvx | 85 | Hep A, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 86 | IG | ||
http://hl7.org/fhir/sid/cvx | 87 | IGIV | ||
http://hl7.org/fhir/sid/cvx | 88 | influenza, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 89 | polio, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 90 | rabies, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 91 | typhoid, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 92 | VEE, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 93 | RSV-MAb | ||
http://hl7.org/fhir/sid/cvx | 94 | MMRV | ||
http://hl7.org/fhir/sid/cvx | 95 | TST-OT tine test | ||
http://hl7.org/fhir/sid/cvx | 96 | TST-PPD intradermal | ||
http://hl7.org/fhir/sid/cvx | 97 | TST-PPD tine test | ||
http://hl7.org/fhir/sid/cvx | 98 | TST, unspecified formulation | ||
http://hl7.org/fhir/sid/cvx | 998 | no vaccine administered | ||
http://snomed.info/sct | 787859002 | Vaccine product | ||
http://snomed.info/sct | 37146000 | Typhus vaccine | ||
http://snomed.info/sct | 409568008 | Pentavalent botulinum toxoid vaccine | ||
http://snomed.info/sct | 428601009 | Paratyphoid vaccine | ||
http://snomed.info/sct | 774618008 | Vaccine product containing only whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) | ||
http://snomed.info/sct | 775641005 | Vaccine product containing only Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) | ||
http://snomed.info/sct | 777725002 | Vaccine product containing only Clostridium tetani toxoid antigen adsorbed (medicinal product) | ||
http://snomed.info/sct | 836368004 | Bacteria antigen-containing vaccine product | ||
http://snomed.info/sct | 836369007 | Virus antigen-containing vaccine product | ||
http://snomed.info/sct | 836374004 | Hepatitis B virus antigen-containing vaccine product | ||
http://snomed.info/sct | 836375003 | Hepatitis A virus antigen-containing vaccine product | ||
http://snomed.info/sct | 836377006 | Vaccine product containing Influenza virus antigen (medicinal product) | ||
http://snomed.info/sct | 836378001 | Japanese encephalitis virus antigen-containing vaccine product | ||
http://snomed.info/sct | 836379009 | Vaccine product containing Human papillomavirus antigen (medicinal product) | ||
http://snomed.info/sct | 836380007 | Vaccine product containing Haemophilus influenzae type b antigen (medicinal product) | ||
http://snomed.info/sct | 836381006 | Corynebacterium diphtheriae antigen-containing vaccine product | ||
http://snomed.info/sct | 836382004 | Vaccine product containing Measles morbillivirus antigen (medicinal product) | ||
http://snomed.info/sct | 836383009 | Vibrio cholerae antigen-containing vaccine product | ||
http://snomed.info/sct | 836384003 | Bacillus anthracis antigen-containing vaccine product | ||
http://snomed.info/sct | 836385002 | Yellow fever virus antigen-containing vaccine product | ||
http://snomed.info/sct | 836387005 | Rotavirus antigen-containing vaccine product | ||
http://snomed.info/sct | 836388000 | Vaccine product containing Rubella virus antigen (medicinal product) | ||
http://snomed.info/sct | 836389008 | Vaccine product containing Vaccinia virus antigen (medicinal product) | ||
http://snomed.info/sct | 836390004 | Vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product) | ||
http://snomed.info/sct | 836393002 | Vaccine product containing Rabies lyssavirus antigen (medicinal product) | ||
http://snomed.info/sct | 836397001 | Vaccine product containing Coxiella burnetii antigen (medicinal product) | ||
http://snomed.info/sct | 836398006 | Vaccine product containing Streptococcus pneumoniae antigen (medicinal product) | ||
http://snomed.info/sct | 836400005 | Adenovirus antigen-containing vaccine product | ||
http://snomed.info/sct | 836401009 | Vaccine product containing Neisseria meningitidis antigen (medicinal product) | ||
http://snomed.info/sct | 836402002 | Bacillus Calmette-Guerin antigen-containing vaccine product | ||
http://snomed.info/sct | 836403007 | Tick-borne encephalitis virus antigen-containing vaccine product | ||
http://snomed.info/sct | 836421005 | Ebolavirus antigen-containing vaccine product | ||
http://snomed.info/sct | 836495005 | Vaccine product containing Human alphaherpesvirus 3 antigen (medicinal product) | ||
http://snomed.info/sct | 836498007 | Vaccine product containing Mumps orthorubulavirus antigen (medicinal product) | ||
http://snomed.info/sct | 836500008 | Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | ||
http://snomed.info/sct | 840549009 | Vaccine product containing Yersinia pestis antigen (medicinal product) | ||
http://snomed.info/sct | 840551008 | Vaccine product containing Francisella tularensis antigen (medicinal product) | ||
http://snomed.info/sct | 840563003 | Vaccine product containing Dengue virus antigen (medicinal product) | ||
http://snomed.info/sct | 840564009 | Vaccine product containing Leptospira antigen (medicinal product) | ||
http://snomed.info/sct | 840599008 | Borrelia burgdorferi antigen-containing vaccine product | ||
http://snomed.info/sct | 860722004 | Vaccine product containing Junin virus antigen (medicinal product) | ||
http://snomed.info/sct | 860818003 | Bacillus anthracis antigen only vaccine product | ||
http://snomed.info/sct | 863911006 | Vaccine product containing Clostridium tetani antigen (medicinal product) | ||
http://snomed.info/sct | 863950005 | Bacteria and virus antigens-containing vaccine product | ||
http://snomed.info/sct | 865997008 | Hepatitis A virus antigen only adult vaccine product | ||
http://snomed.info/sct | 871716003 | Tularemia vaccine | ||
http://snomed.info/sct | 871717007 | Vaccine product containing only Yellow fever virus antigen (medicinal product) | ||
http://snomed.info/sct | 871718002 | Plague vaccine | ||
http://snomed.info/sct | 871719005 | Tick-borne encephalitis virus antigen only vaccine product | ||
http://snomed.info/sct | 871720004 | Vaccine product containing only Dengue virus antigen (medicinal product) | ||
http://snomed.info/sct | 871721000 | Vaccine product containing only Ebolavirus antigen (medicinal product) | ||
http://snomed.info/sct | 871722007 | Adenovirus antigen only vaccine product | ||
http://snomed.info/sct | 871723002 | Coxiella burnetii antigen only vaccine product | ||
http://snomed.info/sct | 871724008 | Japanese encephalitis virus antigen only vaccine product | ||
http://snomed.info/sct | 871725009 | Vaccine product containing only inactivated whole Japanese encephalitis virus antigen (medicinal product) | ||
http://snomed.info/sct | 871726005 | Rabies vaccine | ||
http://snomed.info/sct | 871727001 | Vaccine product containing only Vaccinia virus antigen (medicinal product) | ||
http://snomed.info/sct | 871729003 | Corynebacterium diphtheriae antigen only vaccine product | ||
http://snomed.info/sct | 871730008 | Low dose diphtheria vaccine | ||
http://snomed.info/sct | 871732000 | Rubella virus antigen only vaccine product | ||
http://snomed.info/sct | 871737006 | Mumps orthorubulavirus antigen only vaccine product | ||
http://snomed.info/sct | 871738001 | Live attenuated mumps vaccine | ||
http://snomed.info/sct | 871739009 | Vaccine product containing only Human poliovirus antigen (medicinal product) | ||
http://snomed.info/sct | 871740006 | Inactivated whole Human poliovirus antigen only vaccine product | ||
http://snomed.info/sct | 871742003 | Vaccine product containing only Clostridium tetani antigen (medicinal product) | ||
http://snomed.info/sct | 871750007 | Hepatitis A virus antigen only paediatric vaccine product | ||
http://snomed.info/sct | 871751006 | Vaccine product containing only Hepatitis A virus antigen (medicinal product) | ||
http://snomed.info/sct | 871755002 | Typhoid Vi capsular polysaccharide vaccine | ||
http://snomed.info/sct | 871758000 | Pertussis vaccine | ||
http://snomed.info/sct | 871759008 | Acellular Bordetella pertussis only vaccine product | ||
http://snomed.info/sct | 871761004 | Rotavirus vaccine | ||
http://snomed.info/sct | 871764007 | Haemophilus influenzae type b vaccine | ||
http://snomed.info/sct | 871765008 | Measles vaccine | ||
http://snomed.info/sct | 871766009 | Live attenuated Measles morbillivirus antigen only vaccine product | ||
http://snomed.info/sct | 871768005 | Influenza virus antigen only vaccine product in nasal dose form | ||
http://snomed.info/sct | 871772009 | Influenza H1N1 vaccine | ||
http://snomed.info/sct | 871803007 | Vaccine product containing only Hepatitis A and Hepatitis B virus antigens (medicinal product) | ||
http://snomed.info/sct | 871804001 | Hepatitis A virus and Salmonella enterica subspecies enterica serovar Typhi antigens only vaccine product | ||
http://snomed.info/sct | 871806004 | Haemophilus influenzae type b and Hepatitis B virus antigens only vaccine product | ||
http://snomed.info/sct | 871816007 | Vaccine product containing only Clostridium tetani and Human poliovirus antigens (medicinal product) | ||
http://snomed.info/sct | 871817003 | Measles morbillivirus and Rubella virus antigens only vaccine product | ||
http://snomed.info/sct | 871822003 | Hepatitis B virus antigen only vaccine product | ||
http://snomed.info/sct | 871825001 | Inactivated Japanese encephalitis virus adsorbed vaccine | ||
http://snomed.info/sct | 871826000 | Diphtheria and tetanus vaccine | ||
http://snomed.info/sct | 871827009 | Low dose diphtheria and tetanus vaccine | ||
http://snomed.info/sct | 871830002 | Corynebacterium diphtheriae toxoid antigen-containing vaccine product | ||
http://snomed.info/sct | 871831003 | Vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | ||
http://snomed.info/sct | 871837004 | Vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (medicinal product) | ||
http://snomed.info/sct | 871838009 | Vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated Human poliovirus antigens (medicinal product) | ||
http://snomed.info/sct | 871839001 | Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens only vaccine product | ||
http://snomed.info/sct | 871866001 | Vaccine product containing only Neisseria meningitidis serogroup C antigen (medicinal product) | ||
http://snomed.info/sct | 871871008 | Meningitis A and C vaccine | ||
http://snomed.info/sct | 871873006 | Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (medicinal product) | ||
http://snomed.info/sct | 871875004 | Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product) | ||
http://snomed.info/sct | 871876003 | Diphtheria and acellular pertussis and tetanus vaccine | ||
http://snomed.info/sct | 871878002 | Diphtheria and pertussis and poliomyelitis and tetanus vaccine | ||
http://snomed.info/sct | 871883005 | Pediatric vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (medicinal product) | ||
http://snomed.info/sct | 871886002 | Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens only vaccine product | ||
http://snomed.info/sct | 871887006 | Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (medicinal product) | ||
http://snomed.info/sct | 871888001 | Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated Human poliovirus antigens only vaccine product | ||
http://snomed.info/sct | 871889009 | Diphtheria and hepatitis B and inactivated poliomyelitis and acellular pertussis vaccine | ||
http://snomed.info/sct | 871890000 | Vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (medicinal product) | ||
http://snomed.info/sct | 871891001 | Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B and inactivated whole Human poliovirus antigens only vaccine product | ||
http://snomed.info/sct | 871893003 | Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and inactivated Human poliovirus antigens only vaccine product | ||
http://snomed.info/sct | 871894009 | Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (medicinal product) | ||
http://snomed.info/sct | 871895005 | Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and Human poliovirus antigens (medicinal product) | ||
http://snomed.info/sct | 871897002 | Rocky Mountain spotted fever vaccine | ||
http://snomed.info/sct | 871908002 | Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens only vaccine product | ||
http://snomed.info/sct | 871911001 | Vaccine product containing only Borrelia burgdorferi antigen (medicinal product) | ||
http://snomed.info/sct | 871916006 | Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular oligosaccharide conjugated antigens (medicinal product) | ||
http://snomed.info/sct | 871918007 | Rickettsia antigen-containing vaccine product | ||
http://snomed.info/sct | 871919004 | Human alphaherpesvirus 3 antigen only vaccine product | ||
http://snomed.info/sct | 871921009 | Staphylococcus toxoid vaccine (medicinal product) | ||
http://snomed.info/sct | 871925000 | Hepatitis B surface antigen vaccine | ||
http://snomed.info/sct | 871928003 | Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus and Measles morbillivirus antigens only vaccine product | ||
http://snomed.info/sct | 871929006 | Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus antigens only vaccine product | ||
http://snomed.info/sct | 1003499009 | Vaccine product containing only Influenza A virus subtype H5N1 antigen (medicinal product) | ||
http://snomed.info/sct | 1010308001 | Vaccine product containing only inactivated whole Hepatitis A virus HM-175 strain antigen (medicinal product) | ||
http://snomed.info/sct | 1010310004 | Live attenuated Human alphaherpesvirus 3 Oka-Merck strain only vaccine product | ||
http://snomed.info/sct | 1010313002 | Vaccine product containing only live attenuated Influenza virus antigen (medicinal product) | ||
http://snomed.info/sct | 1010318006 | Inactivated whole Hepatitis A GBM strain vaccine | ||
http://snomed.info/sct | 1010322001 | Vaccine product containing only live attenuated Human alphaherpesvirus 3 Oka strain antigen (medicinal product) | ||
http://snomed.info/sct | 1010689004 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid vaccine | ||
http://snomed.info/sct | 1052328007 | Pneumococcal 4, 6B, 9V, 14, 18C, 19F, and 23F conjugate vaccine | ||
http://snomed.info/sct | 1052330009 | Pneumococcal 10-valent conjugate vaccine | ||
http://snomed.info/sct | 1119220001 | Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens only vaccine product | ||
http://snomed.info/sct | 1119279002 | Inactivated whole Influenza A virus subtype H5N1 antigen only vaccine product | ||
http://snomed.info/sct | 1119305005 | 2019 novel coronavirus antigen vaccine | ||
http://snomed.info/sct | 1119349007 | Severe acute respiratory syndrome coronavirus 2 mRNA only vaccine product | ||
http://snomed.info/sct | 1119351006 | Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | ||
http://snomed.info/sct | 1156183006 | Vaccine product containing only Human alphaherpesvirus 3 recombinant surface glycoprotein E antigen (medicinal product) | ||
http://snomed.info/sct | 1156879008 | Diphtheria and hepatitis B and pertussis and tetanus vaccine | ||
http://snomed.info/sct | 1157024006 | Inactivated whole SARS-CoV-2 antigen vaccine | ||
http://snomed.info/sct | 1157356006 | Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion hemagglutinin antigen only vaccine product | ||
http://snomed.info/sct | 1162629006 | Influenza A virus A/Indonesia/05/2005 (H5N1)-like virus strain split virion hemagglutinin antigen only vaccine product | ||
http://snomed.info/sct | 1162634005 | Acellular Bordetella pertussis, Clostridium tetani toxoid, Corynebacterium diphtheriae toxoid, Haemophilus influenzae type b conjugated, Hepatitis B virus and inactivated Human poliovirus antigens only pediatric vaccine product | ||
http://snomed.info/sct | 1162637003 | Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens only vaccine product | ||
http://snomed.info/sct | 1162643001 | Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen only vaccine product | ||
http://snomed.info/sct | 1187593009 | Vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (medicinal product) | ||
http://snomed.info/sct | 1209197008 | Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) | ||
http://snomed.info/sct | 1252690003 | Meningococcus serogroup A vaccine | ||
http://snomed.info/sct | 1252703004 | Vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus (medicinal product) | ||
http://snomed.info/sct | 1252708008 | Pneumococcal 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F conjugate vaccine | ||
http://snomed.info/sct | 1252709000 | Pneumococcal 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F conjugate vaccine | ||
http://snomed.info/sct | 1254676002 | Vaccine product containing live attenuated virus antigen (medicinal product) | ||
http://snomed.info/sct | 1269346004 | Vaccine product containing only live attenuated Vaccinia virus antigen (medicinal product) | ||
http://snomed.info/sct | 1287338003 | Tick-borne encephalitis virus antigen only paediatric vaccine product | ||
http://snomed.info/sct | 1287595003 | Pediatric vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product) | ||
http://snomed.info/sct | 1287596002 | Adult vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid | ||
http://snomed.info/sct | 1287964002 | B lineage SARS-CoV-2 monovalent mRNA only vaccine product | ||
http://snomed.info/sct | 1290123005 | Vaccine product containing protozoa antigen (medicinal product) | ||
http://snomed.info/sct | 1290624003 | Vaccine product containing Variola virus antigen (medicinal product) | ||
http://snomed.info/sct | 1290625002 | Variola virus antigen only vaccine product | ||
http://snomed.info/sct | 1290764006 | Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens (medicinal product) | ||
http://snomed.info/sct | 1293025000 | Vaccine product containing only modified Vaccinia virus Ankara antigen (medicinal product) | ||
http://snomed.info/sct | 1296676008 | Hepatitis B recombinant adsorbed surface antigen vaccine | ||
http://snomed.info/sct | 1296677004 | Hepatitis B high dose recombinant surface antigen vaccine | ||
http://snomed.info/sct | 1296678009 | 3 antigen Hepatitis B recombinant surface only vaccine product | ||
http://snomed.info/sct | 1296753004 | Paediatric vaccine inactivated whole Hepatitis A and Hepatitis B surface antigens only vaccine product | ||
http://snomed.info/sct | 1296864005 | Paediatric Hepatitis B recombinant adsorbed surface antigen only vaccine product | ||
http://snomed.info/sct | 1297215000 | Live attenuated rubella vaccine | ||
http://snomed.info/sct | 1297217008 | Pediatric vaccine product containing only acellular Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid antigens (medicinal product) | ||
http://snomed.info/sct | 1304283008 | Vaccine product containing only Hepatitis B virus recombinant surface antigen (medicinal product) | ||
http://snomed.info/sct | 1345036005 | Vaccine product containing only live attenuated Chikungunya virus antigen (medicinal product) | ||
http://snomed.info/sct | 1345042009 | Chikungunya virus antigen-containing vaccine product | ||
http://snomed.info/sct | 1345202008 | Vaccine product containing only Chikungunya virus antigen (medicinal product) | ||
http://snomed.info/sct | 91000221102 | Vaccine product containing only inactivated whole Hepatitis A virus antigen (medicinal product) | ||
http://snomed.info/sct | 121000221105 | Vaccine product containing only inactivated whole Hepatitis A and Hepatitis B surface antigens (medicinal product) | ||
http://snomed.info/sct | 601000221108 | Bordetella pertussis antigen-containing vaccine product | ||
http://snomed.info/sct | 911000221103 | Vaccine product containing only Human papillomavirus antigen (medicinal product) | ||
http://snomed.info/sct | 921000221108 | Neisseria meningitidis antigen only vaccine product | ||
http://snomed.info/sct | 951000221102 | Vaccine product containing only Neisseria meningitidis serogroup C capsular polysaccharide conjugated antigen (medicinal product) | ||
http://snomed.info/sct | 961000221100 | Typhoid vaccine | ||
http://snomed.info/sct | 971000221109 | Live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen only vaccine product in oral dose form | ||
http://snomed.info/sct | 981000221107 | Pneumococcal vaccine | ||
http://snomed.info/sct | 991000221105 | Cholera vaccine | ||
http://snomed.info/sct | 1001000221103 | Inactivated cholera vaccine in oral dose form | ||
http://snomed.info/sct | 1011000221100 | Live attenuated Vibrio cholerae antigen only vaccine product in oral dose form | ||
http://snomed.info/sct | 1031000221108 | Vaccine product containing Human poliovirus antigen (medicinal product) | ||
http://snomed.info/sct | 1051000221104 | Live attenuated poliovirus serotypes 1 and 3 vaccine in oral dose form | ||
http://snomed.info/sct | 1061000221102 | Vaccine product containing only Neisseria meningitidis capsular polysaccharide antigen (medicinal product) | ||
http://snomed.info/sct | 1081000221109 | Vaccine product containing only live attenuated Rotavirus antigen (medicinal product) | ||
http://snomed.info/sct | 1101000221104 | Vaccine product containing Clostridium tetani toxoid antigen (medicinal product) | ||
http://snomed.info/sct | 1111000221101 | Vaccine product containing only live attenuated Junin virus antigen (medicinal product) | ||
http://snomed.info/sct | 1121000221106 | Vaccine product containing only live attenuated Yellow fever virus antigen (medicinal product) | ||
http://snomed.info/sct | 1131000221109 | Vaccine product containing only inactivated whole Rabies lyssavirus antigen | ||
http://snomed.info/sct | 1181000221105 | Influenza virus antigen only vaccine product | ||
http://snomed.info/sct | 1801000221105 | Vaccine product containing only Streptococcus pneumoniae capsular polysaccharide antigen conjugated (medicinal product) | ||
http://snomed.info/sct | 1861000221106 | Bacillus Calmette-Guerin vaccine | ||
http://snomed.info/sct | 1971000221105 | Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) | ||
http://snomed.info/sct | 1981000221108 | Vaccine product containing only Neisseria meningitidis serogroup B antigen (medicinal product) | ||
http://snomed.info/sct | 1991000221106 | Vaccine product containing only Human papillomavirus 16 and 18 antigens (medicinal product) | ||
http://snomed.info/sct | 2001000221108 | Human papillomavirus 6, 11, 16 and 18 antigens only vaccine product | ||
http://snomed.info/sct | 2021000221101 | Tetanus toxoid vaccine | ||
http://snomed.info/sct | 2031000221103 | Adult vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae toxoids (medicinal product) | ||
http://snomed.info/sct | 2041000221105 | Haemophilus influenzae type b capsular polysaccharide conjugated vaccine | ||
http://snomed.info/sct | 2051000221107 | Adult vaccine product containing only acellular Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid antigens (medicinal product) | ||
http://snomed.info/sct | 2061000221109 | Pediatric vaccine product containing only whole cell Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid (medicinal product) | ||
http://snomed.info/sct | 2071000221100 | Whole cell Bordetella pertussis and Corynebacterium diphtheriae toxoid and Clostridium tetani toxoid and Haemophilus influenzae type b capsular polysaccharide conjugated antigens only pediatric vaccine | ||
http://snomed.info/sct | 2081000221102 | Diphtheria toxoid, Haemophilus influenzae type b conjugate, hepatitis B surface antigen, acellular pertussis and tetanus toxoid pediatric vaccine | ||
http://snomed.info/sct | 2091000221104 | Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens only paediatric vaccine product | ||
http://snomed.info/sct | 2101000221107 | Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and poliomyelitis and tetanus pediatric vaccine | ||
http://snomed.info/sct | 2171000221104 | Typhoid polysaccharide vaccine in parenteral dose form | ||
http://snomed.info/sct | 2181000221101 | Vibrio cholerae antigen only vaccine product in oral dose form | ||
http://snomed.info/sct | 2191000221103 | Inactivated rabies vaccine grown in cellular line | ||
http://snomed.info/sct | 2201000221100 | Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in brain tissue (medicinal product) | ||
http://snomed.info/sct | 2211000221102 | Influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria lineage antigens only vaccine product | ||
http://snomed.info/sct | 2221000221107 | Live attenuated Human alphaherpesvirus 3 only vaccine product | ||
http://snomed.info/sct | 2231000221105 | Vaccine product containing only live attenuated Measles morbillivirus and Rubella virus antigens (medicinal product) | ||
http://snomed.info/sct | 2241000221103 | Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (medicinal product) | ||
http://snomed.info/sct | 2251000221101 | Vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (medicinal product) | ||
http://snomed.info/sct | 2261000221104 | Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) | ||
http://snomed.info/sct | 28531000087107 | COVID-19 vaccine | ||
http://snomed.info/sct | 29061000087103 | COVID-19 non-replicating viral vector vaccine | ||
http://snomed.info/sct | 30141000087107 | COVID-19 virus-like particle antigen vaccine | ||
http://snomed.info/sct | 45861000087106 | Vaccine product containing Plasmodium falciparum antigen (medicinal product) | ||
http://snomed.info/sct | 45891000087103 | Live attenuated Zaire ebolavirus antigen only vaccine product | ||
http://snomed.info/sct | 51311000087100 | RSV (respiratory syncytial virus) vaccine | ||
http://snomed.info/sct | 51451000087105 | Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product) | ||
http://snomed.info/sct | 51591000087104 | Vaccine product containing only Enterovirus A71 antigen | ||
http://snomed.info/sct | 52821000087108 | Vaccine product containing only Neisseria meningitidis serogroup A capsular polysaccharide conjugated antigen (medicinal product) | ||
http://snomed.info/sct | 318341000221109 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and acellular pertussis and tetanus toxoid pediatric vaccine | ||
http://snomed.info/sct | 318351000221106 | Pediatric vaccine product containing only acellular Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid and inactivated whole Human Poliovirus serotype 1, 2 and 3 antigens (medicinal product) | ||
http://snomed.info/sct | 319941000221104 | Live attenuated Mycobacterium bovis antigen only vaccine product in parenteral dose form | ||
http://snomed.info/sct | 462321000124107 | Low dose acellular Bordetella pertussis and Clostridium tetani and low dose Corynebacterium diphtheriae antigens only vaccine product | ||
http://www.whocc.no/atc | A | ALIMENTARY TRACT AND METABOLISM | ||
http://www.whocc.no/atc | A01 | STOMATOLOGICAL PREPARATIONS | ||
http://www.whocc.no/atc | A01A | STOMATOLOGICAL PREPARATIONS | ||
http://www.whocc.no/atc | A01AA | Caries prophylactic agents | ||
http://www.whocc.no/atc | A01AA01 | sodium fluoride | ||
http://www.whocc.no/atc | A01AA02 | sodium monofluorophosphate | ||
http://www.whocc.no/atc | A01AA03 | olaflur | ||
http://www.whocc.no/atc | A01AA04 | stannous fluoride | ||
http://www.whocc.no/atc | A01AA30 | combinations | ||
http://www.whocc.no/atc | A01AA51 | sodium fluoride, combinations | ||
http://www.whocc.no/atc | A01AB | Antiinfectives and antiseptics for local oral treatment | ||
http://www.whocc.no/atc | A01AB02 | hydrogen peroxide | ||
http://www.whocc.no/atc | A01AB03 | chlorhexidine | ||
http://www.whocc.no/atc | A01AB04 | amphotericin B | ||
http://www.whocc.no/atc | A01AB05 | polynoxylin | ||
http://www.whocc.no/atc | A01AB06 | domiphen | ||
http://www.whocc.no/atc | A01AB07 | oxyquinoline | ||
http://www.whocc.no/atc | A01AB08 | neomycin | ||
http://www.whocc.no/atc | A01AB09 | miconazole | ||
http://www.whocc.no/atc | A01AB10 | natamycin | ||
http://www.whocc.no/atc | A01AB11 | various | ||
http://www.whocc.no/atc | A01AB12 | hexetidine | ||
http://www.whocc.no/atc | A01AB13 | tetracycline | ||
http://www.whocc.no/atc | A01AB14 | benzoxonium chloride | ||
http://www.whocc.no/atc | A01AB15 | tibezonium iodide | ||
http://www.whocc.no/atc | A01AB16 | mepartricin | ||
http://www.whocc.no/atc | A01AB17 | metronidazole | ||
http://www.whocc.no/atc | A01AB18 | clotrimazole | ||
http://www.whocc.no/atc | A01AB19 | sodium perborate | ||
http://www.whocc.no/atc | A01AB21 | chlortetracycline | ||
http://www.whocc.no/atc | A01AB22 | doxycycline | ||
http://www.whocc.no/atc | A01AB23 | minocycline | ||
http://www.whocc.no/atc | A01AB24 | octenidine | ||
http://www.whocc.no/atc | A01AB25 | oxytetracycline | ||
http://www.whocc.no/atc | A01AB53 | chlorhexidine and cetylpyridinium | ||
http://www.whocc.no/atc | A01AC | Corticosteroids for local oral treatment | ||
http://www.whocc.no/atc | A01AC01 | triamcinolone | ||
http://www.whocc.no/atc | A01AC02 | dexamethasone | ||
http://www.whocc.no/atc | A01AC03 | hydrocortisone | ||
http://www.whocc.no/atc | A01AC04 | prednisolone | ||
http://www.whocc.no/atc | A01AC54 | prednisolone, combinations | ||
http://www.whocc.no/atc | A01AD | Other agents for local oral treatment | ||
http://www.whocc.no/atc | A01AD01 | epinephrine | ||
http://www.whocc.no/atc | A01AD02 | benzydamine | ||
http://www.whocc.no/atc | A01AD05 | acetylsalicylic acid | ||
http://www.whocc.no/atc | A01AD06 | adrenalone | ||
http://www.whocc.no/atc | A01AD07 | amlexanox | ||
http://www.whocc.no/atc | A01AD08 | becaplermin | ||
http://www.whocc.no/atc | A01AD11 | various | ||
http://www.whocc.no/atc | A02 | DRUGS FOR ACID RELATED DISORDERS | ||
http://www.whocc.no/atc | A02A | ANTACIDS | ||
http://www.whocc.no/atc | A02AA | Magnesium compounds | ||
http://www.whocc.no/atc | A02AA01 | magnesium carbonate | ||
http://www.whocc.no/atc | A02AA02 | magnesium oxide | ||
http://www.whocc.no/atc | A02AA03 | magnesium peroxide | ||
http://www.whocc.no/atc | A02AA04 | magnesium hydroxide | ||
http://www.whocc.no/atc | A02AA05 | magnesium silicate | ||
http://www.whocc.no/atc | A02AA10 | combinations | ||
http://www.whocc.no/atc | A02AB | Aluminium compounds | ||
http://www.whocc.no/atc | A02AB01 | aluminium hydroxide | ||
http://www.whocc.no/atc | A02AB02 | algeldrate | ||
http://www.whocc.no/atc | A02AB03 | aluminium phosphate | ||
http://www.whocc.no/atc | A02AB04 | dihydroxialumini sodium carbonate | ||
http://www.whocc.no/atc | A02AB05 | aluminium acetoacetate | ||
http://www.whocc.no/atc | A02AB06 | aloglutamol | ||
http://www.whocc.no/atc | A02AB07 | aluminium glycinate | ||
http://www.whocc.no/atc | A02AB10 | combinations | ||
http://www.whocc.no/atc | A02AC | Calcium compounds | ||
http://www.whocc.no/atc | A02AC01 | calcium carbonate | ||
http://www.whocc.no/atc | A02AC02 | calcium silicate | ||
http://www.whocc.no/atc | A02AC10 | combinations | ||
http://www.whocc.no/atc | A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds | ||
http://www.whocc.no/atc | A02AD01 | ordinary salt combinations | ||
http://www.whocc.no/atc | A02AD02 | magaldrate | ||
http://www.whocc.no/atc | A02AD03 | almagate | ||
http://www.whocc.no/atc | A02AD04 | hydrotalcite | ||
http://www.whocc.no/atc | A02AD05 | almasilate | ||
http://www.whocc.no/atc | A02AF | Antacids with antiflatulents | ||
http://www.whocc.no/atc | A02AF01 | magaldrate and antiflatulents | ||
http://www.whocc.no/atc | A02AF02 | ordinary salt combinations and antiflatulents | ||
http://www.whocc.no/atc | A02AG | Antacids with antispasmodics | ||
http://www.whocc.no/atc | A02AH | Antacids with sodium bicarbonate | ||
http://www.whocc.no/atc | A02AX | Antacids, other combinations | ||
http://www.whocc.no/atc | A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | ||
http://www.whocc.no/atc | A02BA | H2-receptor antagonists | ||
http://www.whocc.no/atc | A02BA01 | cimetidine | ||
http://www.whocc.no/atc | A02BA02 | ranitidine | ||
http://www.whocc.no/atc | A02BA03 | famotidine | ||
http://www.whocc.no/atc | A02BA04 | nizatidine | ||
http://www.whocc.no/atc | A02BA05 | niperotidine | ||
http://www.whocc.no/atc | A02BA06 | roxatidine | ||
http://www.whocc.no/atc | A02BA07 | ranitidine bismuth citrate | ||
http://www.whocc.no/atc | A02BA08 | lafutidine | ||
http://www.whocc.no/atc | A02BA51 | cimetidine, combinations | ||
http://www.whocc.no/atc | A02BA53 | famotidine, combinations | ||
http://www.whocc.no/atc | A02BB | Prostaglandins | ||
http://www.whocc.no/atc | A02BB01 | misoprostol | ||
http://www.whocc.no/atc | A02BB02 | enprostil | ||
http://www.whocc.no/atc | A02BC | Proton pump inhibitors | ||
http://www.whocc.no/atc | A02BC01 | omeprazole | ||
http://www.whocc.no/atc | A02BC02 | pantoprazole | ||
http://www.whocc.no/atc | A02BC03 | lansoprazole | ||
http://www.whocc.no/atc | A02BC04 | rabeprazole | ||
http://www.whocc.no/atc | A02BC05 | esomeprazole | ||
http://www.whocc.no/atc | A02BC06 | dexlansoprazole | ||
http://www.whocc.no/atc | A02BC07 | dexrabeprazole | ||
http://www.whocc.no/atc | A02BC08 | vonoprazan | ||
http://www.whocc.no/atc | A02BC09 | tegoprazan | ||
http://www.whocc.no/atc | A02BC10 | fexuprazan | ||
http://www.whocc.no/atc | A02BC11 | ilaprazole | ||
http://www.whocc.no/atc | A02BC51 | omeprazole, combinations | ||
http://www.whocc.no/atc | A02BC53 | lansoprazole, combinations | ||
http://www.whocc.no/atc | A02BC54 | rabeprazole, combinations | ||
http://www.whocc.no/atc | A02BD | Combinations for eradication of Helicobacter pylori | ||
http://www.whocc.no/atc | A02BD01 | omeprazole, amoxicillin and metronidazole | ||
http://www.whocc.no/atc | A02BD02 | lansoprazole, tetracycline and metronidazole | ||
http://www.whocc.no/atc | A02BD03 | lansoprazole, amoxicillin and metronidazole | ||
http://www.whocc.no/atc | A02BD04 | pantoprazole, amoxicillin and clarithromycin | ||
http://www.whocc.no/atc | A02BD05 | omeprazole, amoxicillin and clarithromycin | ||
http://www.whocc.no/atc | A02BD06 | esomeprazole, amoxicillin and clarithromycin | ||
http://www.whocc.no/atc | A02BD07 | lansoprazole, amoxicillin and clarithromycin | ||
http://www.whocc.no/atc | A02BD08 | bismuth subcitrate, tetracycline and metronidazole | ||
http://www.whocc.no/atc | A02BD09 | lansoprazole, clarithromycin and tinidazole | ||
http://www.whocc.no/atc | A02BD10 | lansoprazole, amoxicillin and levofloxacin | ||
http://www.whocc.no/atc | A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole | ||
http://www.whocc.no/atc | A02BD12 | rabeprazole, amoxicillin and clarithromycin | ||
http://www.whocc.no/atc | A02BD13 | rabeprazole, amoxicillin and metronidazole | ||
http://www.whocc.no/atc | A02BD14 | vonoprazan, amoxicillin and clarithromycin | ||
http://www.whocc.no/atc | A02BD15 | vonoprazan, amoxicillin and metronidazole | ||
http://www.whocc.no/atc | A02BD16 | omeprazole, amoxicillin and rifabutin | ||
http://www.whocc.no/atc | A02BD17 | vonoprazan and amoxicillin | ||
http://www.whocc.no/atc | A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | ||
http://www.whocc.no/atc | A02BX01 | carbenoxolone | ||
http://www.whocc.no/atc | A02BX02 | sucralfate | ||
http://www.whocc.no/atc | A02BX03 | pirenzepine | ||
http://www.whocc.no/atc | A02BX04 | methiosulfonium chloride | ||
http://www.whocc.no/atc | A02BX05 | bismuth subcitrate | ||
http://www.whocc.no/atc | A02BX06 | proglumide | ||
http://www.whocc.no/atc | A02BX07 | gefarnate | ||
http://www.whocc.no/atc | A02BX08 | sulglicotide | ||
http://www.whocc.no/atc | A02BX09 | acetoxolone | ||
http://www.whocc.no/atc | A02BX10 | zolimidine | ||
http://www.whocc.no/atc | A02BX11 | troxipide | ||
http://www.whocc.no/atc | A02BX12 | bismuth subnitrate | ||
http://www.whocc.no/atc | A02BX13 | alginic acid | ||
http://www.whocc.no/atc | A02BX14 | rebamipide | ||
http://www.whocc.no/atc | A02BX15 | teprenone | ||
http://www.whocc.no/atc | A02BX16 | irsogladine | ||
http://www.whocc.no/atc | A02BX51 | carbenoxolone, combinations excl. psycholeptics | ||
http://www.whocc.no/atc | A02BX71 | carbenoxolone, combinations with psycholeptics | ||
http://www.whocc.no/atc | A02BX77 | gefarnate, combinations with psycholeptics | ||
http://www.whocc.no/atc | A02X | OTHER DRUGS FOR ACID RELATED DISORDERS | ||
http://www.whocc.no/atc | A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | ||
http://www.whocc.no/atc | A03A | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | ||
http://www.whocc.no/atc | A03AA | Synthetic anticholinergics, esters with tertiary amino group | ||
http://www.whocc.no/atc | A03AA01 | oxyphencyclimine | ||
http://www.whocc.no/atc | A03AA03 | camylofin | ||
http://www.whocc.no/atc | A03AA04 | mebeverine | ||
http://www.whocc.no/atc | A03AA05 | trimebutine | ||
http://www.whocc.no/atc | A03AA06 | rociverine | ||
http://www.whocc.no/atc | A03AA07 | dicycloverine | ||
http://www.whocc.no/atc | A03AA08 | dihexyverine | ||
http://www.whocc.no/atc | A03AA09 | difemerine | ||
http://www.whocc.no/atc | A03AA30 | piperidolate | ||
http://www.whocc.no/atc | A03AB | Synthetic anticholinergics, quaternary ammonium compounds | ||
http://www.whocc.no/atc | A03AB01 | benzilone | ||
http://www.whocc.no/atc | A03AB02 | glycopyrronium bromide | ||
http://www.whocc.no/atc | A03AB03 | oxyphenonium | ||
http://www.whocc.no/atc | A03AB04 | penthienate | ||
http://www.whocc.no/atc | A03AB05 | propantheline | ||
http://www.whocc.no/atc | A03AB06 | otilonium bromide | ||
http://www.whocc.no/atc | A03AB07 | methantheline | ||
http://www.whocc.no/atc | A03AB08 | tridihexethyl | ||
http://www.whocc.no/atc | A03AB09 | isopropamide | ||
http://www.whocc.no/atc | A03AB10 | hexocyclium | ||
http://www.whocc.no/atc | A03AB11 | poldine | ||
http://www.whocc.no/atc | A03AB12 | mepenzolate | ||
http://www.whocc.no/atc | A03AB13 | bevonium | ||
http://www.whocc.no/atc | A03AB14 | pipenzolate | ||
http://www.whocc.no/atc | A03AB15 | diphemanil | ||
http://www.whocc.no/atc | A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide | ||
http://www.whocc.no/atc | A03AB17 | tiemonium iodide | ||
http://www.whocc.no/atc | A03AB18 | prifinium bromide | ||
http://www.whocc.no/atc | A03AB19 | timepidium bromide | ||
http://www.whocc.no/atc | A03AB21 | fenpiverinium | ||
http://www.whocc.no/atc | A03AB53 | oxyphenonium, combinations | ||
http://www.whocc.no/atc | A03AC | Synthetic antispasmodics, amides with tertiary amines | ||
http://www.whocc.no/atc | A03AC02 | dimethylaminopropionylphenothiazine | ||
http://www.whocc.no/atc | A03AC04 | nicofetamide | ||
http://www.whocc.no/atc | A03AC05 | tiropramide | ||
http://www.whocc.no/atc | A03AD | Papaverine and derivatives | ||
http://www.whocc.no/atc | A03AD01 | papaverine | ||
http://www.whocc.no/atc | A03AD02 | drotaverine | ||
http://www.whocc.no/atc | A03AD30 | moxaverine | ||
http://www.whocc.no/atc | A03AE | Serotonin receptor antagonists | ||
http://www.whocc.no/atc | A03AE01 | alosetron | ||
http://www.whocc.no/atc | A03AE03 | cilansetron | ||
http://www.whocc.no/atc | A03AX | Other drugs for functional gastrointestinal disorders | ||
http://www.whocc.no/atc | A03AX01 | fenpiprane | ||
http://www.whocc.no/atc | A03AX02 | diisopromine | ||
http://www.whocc.no/atc | A03AX03 | chlorbenzoxamine | ||
http://www.whocc.no/atc | A03AX04 | pinaverium | ||
http://www.whocc.no/atc | A03AX05 | fenoverine | ||
http://www.whocc.no/atc | A03AX06 | idanpramine | ||
http://www.whocc.no/atc | A03AX07 | proxazole | ||
http://www.whocc.no/atc | A03AX08 | alverine | ||
http://www.whocc.no/atc | A03AX09 | trepibutone | ||
http://www.whocc.no/atc | A03AX10 | isometheptene | ||
http://www.whocc.no/atc | A03AX11 | caroverine | ||
http://www.whocc.no/atc | A03AX12 | phloroglucinol | ||
http://www.whocc.no/atc | A03AX13 | silicones | ||
http://www.whocc.no/atc | A03AX14 | valethamate | ||
http://www.whocc.no/atc | A03AX15 | menthae piperitae aetheroleum | ||
http://www.whocc.no/atc | A03AX30 | trimethyldiphenylpropylamine | ||
http://www.whocc.no/atc | A03AX58 | alverine, combinations | ||
http://www.whocc.no/atc | A03B | BELLADONNA AND DERIVATIVES, PLAIN | ||
http://www.whocc.no/atc | A03BA | Belladonna alkaloids, tertiary amines | ||
http://www.whocc.no/atc | A03BA01 | atropine | ||
http://www.whocc.no/atc | A03BA03 | hyoscyamine | ||
http://www.whocc.no/atc | A03BA04 | belladonna total alkaloids | ||
http://www.whocc.no/atc | A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds | ||
http://www.whocc.no/atc | A03BB01 | butylscopolamine | ||
http://www.whocc.no/atc | A03BB02 | methylatropine | ||
http://www.whocc.no/atc | A03BB03 | methylscopolamine | ||
http://www.whocc.no/atc | A03BB04 | fentonium | ||
http://www.whocc.no/atc | A03BB05 | cimetropium bromide | ||
http://www.whocc.no/atc | A03BB06 | homatropine methylbromide | ||
http://www.whocc.no/atc | A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS | ||
http://www.whocc.no/atc | A03CA | Synthetic anticholinergic agents in combination with psycholeptics | ||
http://www.whocc.no/atc | A03CA01 | isopropamide and psycholeptics | ||
http://www.whocc.no/atc | A03CA02 | clidinium and psycholeptics | ||
http://www.whocc.no/atc | A03CA03 | oxyphencyclimine and psycholeptics | ||
http://www.whocc.no/atc | A03CA04 | otilonium bromide and psycholeptics | ||
http://www.whocc.no/atc | A03CA05 | glycopyrronium bromide and psycholeptics | ||
http://www.whocc.no/atc | A03CA06 | bevonium and psycholeptics | ||
http://www.whocc.no/atc | A03CA07 | ambutonium and psycholeptics | ||
http://www.whocc.no/atc | A03CA08 | diphemanil and psycholeptics | ||
http://www.whocc.no/atc | A03CA09 | pipenzolate and psycholeptics | ||
http://www.whocc.no/atc | A03CA30 | emepronium and psycholeptics | ||
http://www.whocc.no/atc | A03CA34 | propantheline and psycholeptics | ||
http://www.whocc.no/atc | A03CB | Belladonna and derivatives in combination with psycholeptics | ||
http://www.whocc.no/atc | A03CB01 | methylscopolamine and psycholeptics | ||
http://www.whocc.no/atc | A03CB02 | belladonna total alkaloids and psycholeptics | ||
http://www.whocc.no/atc | A03CB03 | atropine and psycholeptics | ||
http://www.whocc.no/atc | A03CB04 | homatropine methylbromide and psycholeptics | ||
http://www.whocc.no/atc | A03CB31 | hyoscyamine and psycholeptics | ||
http://www.whocc.no/atc | A03CC | Other antispasmodics in combination with psycholeptics | ||
http://www.whocc.no/atc | A03D | ANTISPASMODICS IN COMBINATION WITH ANALGESICS | ||
http://www.whocc.no/atc | A03DA | Synthetic anticholinergic agents in combination with analgesics | ||
http://www.whocc.no/atc | A03DA01 | tropenzilone and analgesics | ||
http://www.whocc.no/atc | A03DA02 | pitofenone and analgesics | ||
http://www.whocc.no/atc | A03DA03 | bevonium and analgesics | ||
http://www.whocc.no/atc | A03DA04 | ciclonium and analgesics | ||
http://www.whocc.no/atc | A03DA05 | camylofin and analgesics | ||
http://www.whocc.no/atc | A03DA06 | trospium and analgesics | ||
http://www.whocc.no/atc | A03DA07 | tiemonium iodide and analgesics | ||
http://www.whocc.no/atc | A03DB | Belladonna and derivatives in combination with analgesics | ||
http://www.whocc.no/atc | A03DB04 | butylscopolamine and analgesics | ||
http://www.whocc.no/atc | A03DC | Other antispasmodics in combination with analgesics | ||
http://www.whocc.no/atc | A03E | ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS | ||
http://www.whocc.no/atc | A03EA | Antispasmodics, psycholeptics and analgesics in combination | ||
http://www.whocc.no/atc | A03ED | Antispasmodics in combination with other drugs | ||
http://www.whocc.no/atc | A03F | PROPULSIVES | ||
http://www.whocc.no/atc | A03FA | Propulsives | ||
http://www.whocc.no/atc | A03FA01 | metoclopramide | ||
http://www.whocc.no/atc | A03FA02 | cisapride | ||
http://www.whocc.no/atc | A03FA03 | domperidone | ||
http://www.whocc.no/atc | A03FA04 | bromopride | ||
http://www.whocc.no/atc | A03FA05 | alizapride | ||
http://www.whocc.no/atc | A03FA06 | clebopride | ||
http://www.whocc.no/atc | A03FA07 | itopride | ||
http://www.whocc.no/atc | A03FA08 | cinitapride | ||
http://www.whocc.no/atc | A03FA09 | mosapride | ||
http://www.whocc.no/atc | A03FA10 | acotiamide | ||
http://www.whocc.no/atc | A04 | ANTIEMETICS AND ANTINAUSEANTS | ||
http://www.whocc.no/atc | A04A | ANTIEMETICS AND ANTINAUSEANTS | ||
http://www.whocc.no/atc | A04AA | Serotonin (5HT3) antagonists | ||
http://www.whocc.no/atc | A04AA01 | ondansetron | ||
http://www.whocc.no/atc | A04AA02 | granisetron | ||
http://www.whocc.no/atc | A04AA03 | tropisetron | ||
http://www.whocc.no/atc | A04AA04 | dolasetron | ||
http://www.whocc.no/atc | A04AA05 | palonosetron | ||
http://www.whocc.no/atc | A04AA55 | palonosetron, combinations | ||
http://www.whocc.no/atc | A04AD | Other antiemetics | ||
http://www.whocc.no/atc | A04AD01 | scopolamine | ||
http://www.whocc.no/atc | A04AD02 | cerium oxalate | ||
http://www.whocc.no/atc | A04AD04 | chlorobutanol | ||
http://www.whocc.no/atc | A04AD05 | metopimazine | ||
http://www.whocc.no/atc | A04AD10 | dronabinol | ||
http://www.whocc.no/atc | A04AD11 | nabilone | ||
http://www.whocc.no/atc | A04AD12 | aprepitant | ||
http://www.whocc.no/atc | A04AD13 | casopitant | ||
http://www.whocc.no/atc | A04AD14 | rolapitant | ||
http://www.whocc.no/atc | A04AD51 | scopolamine, combinations | ||
http://www.whocc.no/atc | A04AD54 | chlorobutanol, combinations | ||
http://www.whocc.no/atc | A05 | BILE AND LIVER THERAPY | ||
http://www.whocc.no/atc | A05A | BILE THERAPY | ||
http://www.whocc.no/atc | A05AA | Bile acids and derivatives | ||
http://www.whocc.no/atc | A05AA01 | chenodeoxycholic acid | ||
http://www.whocc.no/atc | A05AA02 | ursodeoxycholic acid | ||
http://www.whocc.no/atc | A05AA03 | cholic acid | ||
http://www.whocc.no/atc | A05AA04 | obeticholic acid | ||
http://www.whocc.no/atc | A05AA05 | ursodoxicoltaurine | ||
http://www.whocc.no/atc | A05AB | Preparations for biliary tract therapy | ||
http://www.whocc.no/atc | A05AB01 | nicotinyl methylamide | ||
http://www.whocc.no/atc | A05AX | Other drugs for bile therapy | ||
http://www.whocc.no/atc | A05AX01 | piprozolin | ||
http://www.whocc.no/atc | A05AX02 | hymecromone | ||
http://www.whocc.no/atc | A05AX03 | cyclobutyrol | ||
http://www.whocc.no/atc | A05AX04 | maralixibat chloride | ||
http://www.whocc.no/atc | A05AX05 | odevixibat | ||
http://www.whocc.no/atc | A05AX06 | elafibranor | ||
http://www.whocc.no/atc | A05AX07 | seladelpar | ||
http://www.whocc.no/atc | A05B | LIVER THERAPY, LIPOTROPICS | ||
http://www.whocc.no/atc | A05BA | Liver therapy | ||
http://www.whocc.no/atc | A05BA01 | arginine glutamate | ||
http://www.whocc.no/atc | A05BA03 | silymarin | ||
http://www.whocc.no/atc | A05BA04 | citiolone | ||
http://www.whocc.no/atc | A05BA05 | epomediol | ||
http://www.whocc.no/atc | A05BA06 | ornithine oxoglurate | ||
http://www.whocc.no/atc | A05BA07 | tidiacic arginine | ||
http://www.whocc.no/atc | A05BA08 | glycyrrhizic acid | ||
http://www.whocc.no/atc | A05BA09 | metadoxine | ||
http://www.whocc.no/atc | A05BA10 | phospholipids | ||
http://www.whocc.no/atc | A05C | DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION | ||
http://www.whocc.no/atc | A06 | DRUGS FOR CONSTIPATION | ||
http://www.whocc.no/atc | A06A | DRUGS FOR CONSTIPATION | ||
http://www.whocc.no/atc | A06AA | Softeners, emollients | ||
http://www.whocc.no/atc | A06AA01 | liquid paraffin | ||
http://www.whocc.no/atc | A06AA02 | docusate sodium | ||
http://www.whocc.no/atc | A06AA51 | liquid paraffin, combinations | ||
http://www.whocc.no/atc | A06AB | Contact laxatives | ||
http://www.whocc.no/atc | A06AB01 | oxyphenisatine | ||
http://www.whocc.no/atc | A06AB02 | bisacodyl | ||
http://www.whocc.no/atc | A06AB03 | dantron | ||
http://www.whocc.no/atc | A06AB04 | phenolphthalein | ||
http://www.whocc.no/atc | A06AB05 | castor oil | ||
http://www.whocc.no/atc | A06AB06 | senna glycosides | ||
http://www.whocc.no/atc | A06AB07 | cascara | ||
http://www.whocc.no/atc | A06AB08 | sodium picosulfate | ||
http://www.whocc.no/atc | A06AB09 | bisoxatin | ||
http://www.whocc.no/atc | A06AB20 | contact laxatives in combination | ||
http://www.whocc.no/atc | A06AB30 | contact laxatives in combination with belladonna alkaloids | ||
http://www.whocc.no/atc | A06AB52 | bisacodyl, combinations | ||
http://www.whocc.no/atc | A06AB53 | dantron, combinations | ||
http://www.whocc.no/atc | A06AB56 | senna glycosides, combinations | ||
http://www.whocc.no/atc | A06AB57 | cascara, combinations | ||
http://www.whocc.no/atc | A06AB58 | sodium picosulfate, combinations | ||
http://www.whocc.no/atc | A06AC | Bulk-forming laxatives | ||
http://www.whocc.no/atc | A06AC01 | ispaghula (psylla seeds) | ||
http://www.whocc.no/atc | A06AC02 | ethulose | ||
http://www.whocc.no/atc | A06AC03 | sterculia | ||
http://www.whocc.no/atc | A06AC05 | linseed | ||
http://www.whocc.no/atc | A06AC06 | methylcellulose | ||
http://www.whocc.no/atc | A06AC07 | triticum (wheat fibre) | ||
http://www.whocc.no/atc | A06AC08 | polycarbophil calcium | ||
http://www.whocc.no/atc | A06AC51 | ispaghula, combinations | ||
http://www.whocc.no/atc | A06AC53 | sterculia, combinations | ||
http://www.whocc.no/atc | A06AC55 | linseed, combinations | ||
http://www.whocc.no/atc | A06AD | Osmotically acting laxatives | ||
http://www.whocc.no/atc | A06AD01 | magnesium carbonate | ||
http://www.whocc.no/atc | A06AD02 | magnesium oxide | ||
http://www.whocc.no/atc | A06AD03 | magnesium peroxide | ||
http://www.whocc.no/atc | A06AD04 | magnesium sulfate | ||
http://www.whocc.no/atc | A06AD10 | mineral salts in combination | ||
http://www.whocc.no/atc | A06AD11 | lactulose | ||
http://www.whocc.no/atc | A06AD12 | lactitol | ||
http://www.whocc.no/atc | A06AD13 | sodium sulfate | ||
http://www.whocc.no/atc | A06AD14 | pentaerithrityl | ||
http://www.whocc.no/atc | A06AD15 | macrogol | ||
http://www.whocc.no/atc | A06AD16 | mannitol | ||
http://www.whocc.no/atc | A06AD17 | sodium phosphate | ||
http://www.whocc.no/atc | A06AD18 | sorbitol | ||
http://www.whocc.no/atc | A06AD19 | magnesium citrate | ||
http://www.whocc.no/atc | A06AD21 | sodium tartrate | ||
http://www.whocc.no/atc | A06AD61 | lactulose, combinations | ||
http://www.whocc.no/atc | A06AD65 | macrogol, combinations | ||
http://www.whocc.no/atc | A06AG | Enemas | ||
http://www.whocc.no/atc | A06AG01 | sodium phosphate | ||
http://www.whocc.no/atc | A06AG02 | bisacodyl | ||
http://www.whocc.no/atc | A06AG03 | dantron, incl. combinations | ||
http://www.whocc.no/atc | A06AG04 | glycerol | ||
http://www.whocc.no/atc | A06AG06 | oil | ||
http://www.whocc.no/atc | A06AG07 | sorbitol | ||
http://www.whocc.no/atc | A06AG10 | docusate sodium, incl. combinations | ||
http://www.whocc.no/atc | A06AG11 | sodium lauryl sulfoacetate, incl. combinations | ||
http://www.whocc.no/atc | A06AG20 | combinations | ||
http://www.whocc.no/atc | A06AH | Peripheral opioid receptor antagonists | ||
http://www.whocc.no/atc | A06AH01 | methylnaltrexone bromide | ||
http://www.whocc.no/atc | A06AH02 | alvimopan | ||
http://www.whocc.no/atc | A06AH03 | naloxegol | ||
http://www.whocc.no/atc | A06AH04 | naloxone | ||
http://www.whocc.no/atc | A06AH05 | naldemedine | ||
http://www.whocc.no/atc | A06AX | Other drugs for constipation | ||
http://www.whocc.no/atc | A06AX01 | glycerol | ||
http://www.whocc.no/atc | A06AX02 | carbon dioxide producing drugs | ||
http://www.whocc.no/atc | A06AX03 | lubiprostone | ||
http://www.whocc.no/atc | A06AX04 | linaclotide | ||
http://www.whocc.no/atc | A06AX05 | prucalopride | ||
http://www.whocc.no/atc | A06AX06 | tegaserod | ||
http://www.whocc.no/atc | A06AX07 | plecanatide | ||
http://www.whocc.no/atc | A06AX08 | tenapanor | ||
http://www.whocc.no/atc | A06AX09 | elobixibat | ||
http://www.whocc.no/atc | A07 | ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | ||
http://www.whocc.no/atc | A07A | INTESTINAL ANTIINFECTIVES | ||
http://www.whocc.no/atc | A07AA | Antibiotics | ||
http://www.whocc.no/atc | A07AA01 | neomycin | ||
http://www.whocc.no/atc | A07AA02 | nystatin | ||
http://www.whocc.no/atc | A07AA03 | natamycin | ||
http://www.whocc.no/atc | A07AA04 | streptomycin | ||
http://www.whocc.no/atc | A07AA05 | polymyxin B | ||
http://www.whocc.no/atc | A07AA06 | paromomycin | ||
http://www.whocc.no/atc | A07AA07 | amphotericin B | ||
http://www.whocc.no/atc | A07AA08 | kanamycin | ||
http://www.whocc.no/atc | A07AA09 | vancomycin | ||
http://www.whocc.no/atc | A07AA10 | colistin | ||
http://www.whocc.no/atc | A07AA11 | rifaximin | ||
http://www.whocc.no/atc | A07AA12 | fidaxomicin | ||
http://www.whocc.no/atc | A07AA13 | rifamycin | ||
http://www.whocc.no/atc | A07AA51 | neomycin, combinations | ||
http://www.whocc.no/atc | A07AA54 | streptomycin, combinations | ||
http://www.whocc.no/atc | A07AB | Sulfonamides | ||
http://www.whocc.no/atc | A07AB02 | phthalylsulfathiazole | ||
http://www.whocc.no/atc | A07AB03 | sulfaguanidine | ||
http://www.whocc.no/atc | A07AB04 | succinylsulfathiazole | ||
http://www.whocc.no/atc | A07AC | Imidazole derivatives | ||
http://www.whocc.no/atc | A07AC01 | miconazole | ||
http://www.whocc.no/atc | A07AX | Other intestinal antiinfectives | ||
http://www.whocc.no/atc | A07AX01 | broxyquinoline | ||
http://www.whocc.no/atc | A07AX02 | acetarsol | ||
http://www.whocc.no/atc | A07AX03 | nifuroxazide | ||
http://www.whocc.no/atc | A07AX04 | nifurzide | ||
http://www.whocc.no/atc | A07B | INTESTINAL ADSORBENTS | ||
http://www.whocc.no/atc | A07BA | Charcoal preparations | ||
http://www.whocc.no/atc | A07BA01 | medicinal charcoal | ||
http://www.whocc.no/atc | A07BA51 | medicinal charcoal, combinations | ||
http://www.whocc.no/atc | A07BB | Bismuth preparations | ||
http://www.whocc.no/atc | A07BC | Other intestinal adsorbents | ||
http://www.whocc.no/atc | A07BC01 | pectin | ||
http://www.whocc.no/atc | A07BC02 | kaolin | ||
http://www.whocc.no/atc | A07BC03 | crospovidone | ||
http://www.whocc.no/atc | A07BC04 | attapulgite | ||
http://www.whocc.no/atc | A07BC05 | diosmectite | ||
http://www.whocc.no/atc | A07BC30 | combinations | ||
http://www.whocc.no/atc | A07BC54 | attapulgite, combinations | ||
http://www.whocc.no/atc | A07C | ELECTROLYTES WITH CARBOHYDRATES | ||
http://www.whocc.no/atc | A07CA | Oral rehydration salt formulations | ||
http://www.whocc.no/atc | A07D | ANTIPROPULSIVES | ||
http://www.whocc.no/atc | A07DA | Antipropulsives | ||
http://www.whocc.no/atc | A07DA01 | diphenoxylate | ||
http://www.whocc.no/atc | A07DA02 | opium | ||
http://www.whocc.no/atc | A07DA03 | loperamide | ||
http://www.whocc.no/atc | A07DA04 | difenoxin | ||
http://www.whocc.no/atc | A07DA05 | loperamide oxide | ||
http://www.whocc.no/atc | A07DA06 | eluxadoline | ||
http://www.whocc.no/atc | A07DA52 | morphine, combinations | ||
http://www.whocc.no/atc | A07DA53 | loperamide, combinations | ||
http://www.whocc.no/atc | A07E | INTESTINAL ANTIINFLAMMATORY AGENTS | ||
http://www.whocc.no/atc | A07EA | Corticosteroids acting locally | ||
http://www.whocc.no/atc | A07EA01 | prednisolone | ||
http://www.whocc.no/atc | A07EA02 | hydrocortisone | ||
http://www.whocc.no/atc | A07EA03 | prednisone | ||
http://www.whocc.no/atc | A07EA04 | betamethasone | ||
http://www.whocc.no/atc | A07EA05 | tixocortol | ||
http://www.whocc.no/atc | A07EA06 | budesonide | ||
http://www.whocc.no/atc | A07EA07 | beclometasone | ||
http://www.whocc.no/atc | A07EB | Antiallergic agents, excl. corticosteroids | ||
http://www.whocc.no/atc | A07EB01 | cromoglicic acid | ||
http://www.whocc.no/atc | A07EC | Aminosalicylic acid and similar agents | ||
http://www.whocc.no/atc | A07EC01 | sulfasalazine | ||
http://www.whocc.no/atc | A07EC02 | mesalazine | ||
http://www.whocc.no/atc | A07EC03 | olsalazine | ||
http://www.whocc.no/atc | A07EC04 | balsalazide | ||
http://www.whocc.no/atc | A07F | ANTIDIARRHEAL MICROORGANISMS | ||
http://www.whocc.no/atc | A07FA | Antidiarrheal microorganisms | ||
http://www.whocc.no/atc | A07FA01 | lactic acid producing organisms | ||
http://www.whocc.no/atc | A07FA02 | saccharomyces boulardii | ||
http://www.whocc.no/atc | A07FA03 | escherichia coli | ||
http://www.whocc.no/atc | A07FA51 | lactic acid producing organisms, combinations | ||
http://www.whocc.no/atc | A07X | OTHER ANTIDIARRHEALS | ||
http://www.whocc.no/atc | A07XA | Other antidiarrheals | ||
http://www.whocc.no/atc | A07XA01 | albumin tannate | ||
http://www.whocc.no/atc | A07XA02 | ceratonia | ||
http://www.whocc.no/atc | A07XA03 | calcium compounds | ||
http://www.whocc.no/atc | A07XA04 | racecadotril | ||
http://www.whocc.no/atc | A07XA06 | crofelemer | ||
http://www.whocc.no/atc | A07XA51 | albumin tannate, combinations | ||
http://www.whocc.no/atc | A08 | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | ||
http://www.whocc.no/atc | A08A | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | ||
http://www.whocc.no/atc | A08AA | Centrally acting antiobesity products | ||
http://www.whocc.no/atc | A08AA01 | phentermine | ||
http://www.whocc.no/atc | A08AA02 | fenfluramine | ||
http://www.whocc.no/atc | A08AA03 | amfepramone | ||
http://www.whocc.no/atc | A08AA04 | dexfenfluramine | ||
http://www.whocc.no/atc | A08AA05 | mazindol | ||
http://www.whocc.no/atc | A08AA06 | etilamfetamine | ||
http://www.whocc.no/atc | A08AA07 | cathine | ||
http://www.whocc.no/atc | A08AA08 | clobenzorex | ||
http://www.whocc.no/atc | A08AA09 | mefenorex | ||
http://www.whocc.no/atc | A08AA10 | sibutramine | ||
http://www.whocc.no/atc | A08AA11 | lorcaserin | ||
http://www.whocc.no/atc | A08AA12 | setmelanotide | ||
http://www.whocc.no/atc | A08AA51 | phentermine and topiramate | ||
http://www.whocc.no/atc | A08AA56 | ephedrine, combinations | ||
http://www.whocc.no/atc | A08AA62 | bupropion and naltrexone | ||
http://www.whocc.no/atc | A08AB | Peripherally acting antiobesity products | ||
http://www.whocc.no/atc | A08AB01 | orlistat | ||
http://www.whocc.no/atc | A08AX | Other antiobesity drugs | ||
http://www.whocc.no/atc | A08AX01 | rimonabant | ||
http://www.whocc.no/atc | A09 | DIGESTIVES, INCL. ENZYMES | ||
http://www.whocc.no/atc | A09A | DIGESTIVES, INCL. ENZYMES | ||
http://www.whocc.no/atc | A09AA | Enzyme preparations | ||
http://www.whocc.no/atc | A09AA01 | diastase | ||
http://www.whocc.no/atc | A09AA02 | multienzymes (lipase, protease etc.) | ||
http://www.whocc.no/atc | A09AA03 | pepsin | ||
http://www.whocc.no/atc | A09AA04 | tilactase | ||
http://www.whocc.no/atc | A09AB | Acid preparations | ||
http://www.whocc.no/atc | A09AB01 | glutamic acid hydrochloride | ||
http://www.whocc.no/atc | A09AB02 | betaine hydrochloride | ||
http://www.whocc.no/atc | A09AB03 | hydrochloric acid | ||
http://www.whocc.no/atc | A09AB04 | citric acid | ||
http://www.whocc.no/atc | A09AC | Enzyme and acid preparations, combinations | ||
http://www.whocc.no/atc | A09AC01 | pepsin and acid preparations | ||
http://www.whocc.no/atc | A09AC02 | multienzymes and acid preparations | ||
http://www.whocc.no/atc | A10 | DRUGS USED IN DIABETES | ||
http://www.whocc.no/atc | A10A | INSULINS AND ANALOGUES | ||
http://www.whocc.no/atc | A10AB | Insulins and analogues for injection, fast-acting | ||
http://www.whocc.no/atc | A10AB01 | insulin (human) | ||
http://www.whocc.no/atc | A10AB02 | insulin (beef) | ||
http://www.whocc.no/atc | A10AB03 | insulin (pork) | ||
http://www.whocc.no/atc | A10AB04 | insulin lispro | ||
http://www.whocc.no/atc | A10AB05 | insulin aspart | ||
http://www.whocc.no/atc | A10AB06 | insulin glulisine | ||
http://www.whocc.no/atc | A10AB30 | combinations | ||
http://www.whocc.no/atc | A10AC | Insulins and analogues for injection, intermediate-acting | ||
http://www.whocc.no/atc | A10AC01 | insulin (human) | ||
http://www.whocc.no/atc | A10AC02 | insulin (beef) | ||
http://www.whocc.no/atc | A10AC03 | insulin (pork) | ||
http://www.whocc.no/atc | A10AC04 | insulin lispro | ||
http://www.whocc.no/atc | A10AC30 | combinations | ||
http://www.whocc.no/atc | A10AD | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting | ||
http://www.whocc.no/atc | A10AD01 | insulin (human) | ||
http://www.whocc.no/atc | A10AD02 | insulin (beef) | ||
http://www.whocc.no/atc | A10AD03 | insulin (pork) | ||
http://www.whocc.no/atc | A10AD04 | insulin lispro | ||
http://www.whocc.no/atc | A10AD05 | insulin aspart | ||
http://www.whocc.no/atc | A10AD06 | insulin degludec and insulin aspart | ||
http://www.whocc.no/atc | A10AD30 | combinations | ||
http://www.whocc.no/atc | A10AE | Insulins and analogues for injection, long-acting | ||
http://www.whocc.no/atc | A10AE01 | insulin (human) | ||
http://www.whocc.no/atc | A10AE02 | insulin (beef) | ||
http://www.whocc.no/atc | A10AE03 | insulin (pork) | ||
http://www.whocc.no/atc | A10AE04 | insulin glargine | ||
http://www.whocc.no/atc | A10AE05 | insulin detemir | ||
http://www.whocc.no/atc | A10AE06 | insulin degludec | ||
http://www.whocc.no/atc | A10AE07 | insulin icodec | ||
http://www.whocc.no/atc | A10AE30 | combinations | ||
http://www.whocc.no/atc | A10AE54 | insulin glargine and lixisenatide | ||
http://www.whocc.no/atc | A10AE56 | insulin degludec and liraglutide | ||
http://www.whocc.no/atc | A10AF | Insulins and analogues for inhalation | ||
http://www.whocc.no/atc | A10AF01 | insulin (human) | ||
http://www.whocc.no/atc | A10B | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | ||
http://www.whocc.no/atc | A10BA | Biguanides | ||
http://www.whocc.no/atc | A10BA01 | phenformin | ||
http://www.whocc.no/atc | A10BA02 | metformin | ||
http://www.whocc.no/atc | A10BA03 | buformin | ||
http://www.whocc.no/atc | A10BB | Sulfonylureas | ||
http://www.whocc.no/atc | A10BB01 | glibenclamide | ||
http://www.whocc.no/atc | A10BB02 | chlorpropamide | ||
http://www.whocc.no/atc | A10BB03 | tolbutamide | ||
http://www.whocc.no/atc | A10BB04 | glibornuride | ||
http://www.whocc.no/atc | A10BB05 | tolazamide | ||
http://www.whocc.no/atc | A10BB06 | carbutamide | ||
http://www.whocc.no/atc | A10BB07 | glipizide | ||
http://www.whocc.no/atc | A10BB08 | gliquidone | ||
http://www.whocc.no/atc | A10BB09 | gliclazide | ||
http://www.whocc.no/atc | A10BB10 | metahexamide | ||
http://www.whocc.no/atc | A10BB11 | glisoxepide | ||
http://www.whocc.no/atc | A10BB12 | glimepiride | ||
http://www.whocc.no/atc | A10BB31 | acetohexamide | ||
http://www.whocc.no/atc | A10BC | Sulfonamides (heterocyclic) | ||
http://www.whocc.no/atc | A10BC01 | glymidine | ||
http://www.whocc.no/atc | A10BD | Combinations of oral blood glucose lowering drugs | ||
http://www.whocc.no/atc | A10BD01 | phenformin and sulfonylureas | ||
http://www.whocc.no/atc | A10BD02 | metformin and sulfonylureas | ||
http://www.whocc.no/atc | A10BD03 | metformin and rosiglitazone | ||
http://www.whocc.no/atc | A10BD04 | glimepiride and rosiglitazone | ||
http://www.whocc.no/atc | A10BD05 | metformin and pioglitazone | ||
http://www.whocc.no/atc | A10BD06 | glimepiride and pioglitazone | ||
http://www.whocc.no/atc | A10BD07 | metformin and sitagliptin | ||
http://www.whocc.no/atc | A10BD08 | metformin and vildagliptin | ||
http://www.whocc.no/atc | A10BD09 | pioglitazone and alogliptin | ||
http://www.whocc.no/atc | A10BD10 | metformin and saxagliptin | ||
http://www.whocc.no/atc | A10BD11 | metformin and linagliptin | ||
http://www.whocc.no/atc | A10BD12 | pioglitazone and sitagliptin | ||
http://www.whocc.no/atc | A10BD13 | metformin and alogliptin | ||
http://www.whocc.no/atc | A10BD14 | metformin and repaglinide | ||
http://www.whocc.no/atc | A10BD15 | metformin and dapagliflozin | ||
http://www.whocc.no/atc | A10BD16 | metformin and canagliflozin | ||
http://www.whocc.no/atc | A10BD17 | metformin and acarbose | ||
http://www.whocc.no/atc | A10BD18 | metformin and gemigliptin | ||
http://www.whocc.no/atc | A10BD19 | linagliptin and empagliflozin | ||
http://www.whocc.no/atc | A10BD20 | metformin and empagliflozin |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2020+ Cục Công nghệ thông tin - Bộ Y tế. Package hl7.fhir.vn.core#1.0.0 based on FHIR 4.0.1. Generated 2025-10-23
Links: Table of Contents |
QA Report
| Version History (Re-Build date: 2025/02/11) 
|
|
Propose a change |
In collaboration with Better Health Programme - FHI360